Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Sreedhar A Mandayam Image

      Sreedhar A Mandayam, MD, MPH, MBA, FASN

      Department of Emergency Medicine, Division of Internal Medicine

      Present Title & Affiliation

      Primary Appointment

      Professor, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1995Bangalore Medical College, Bangalore University, Bangalore, IN, Doctor of Medicine, MBBS

      Postgraduate Training

      2016-2016Graduate Certificate in Health Care Management, Rice University, Houston, Texas
      2016-2018MBA, Rice University, Houston, Texas
      2004-2006Clinical Fellowship, Nephrology, University of Texas Medical Branch, Galveston, Texas
      2000-2004Clinical Residency, Residency in Combined Internal Medicine & General Preventive Medicine Program, University of Texas Medical Branch, Galveston, Texas
      2000-2004M.P.H, University of Texas Medical Branch, Galveston, Texas
      1996-1999M.R.C.P, M.R.C.P, London

      Licenses & Certifications

      2017American Board of Internal Medicine in Nephrology
      2014American Board of Preventive Medicine
      2009Texas Medical Board
      2006American Board of Nephrology
      2004American Board of Internal Medicine
      nullWashington State Department of Health
      nullLouisiana State Board of Medical Examiners
      nullMississippi State Board of Medical Licensure
      nullAlabama Board of Medical Examiners
      nullOklahoma State Board of Medical Licensure
      nullTennessee Board of Medical Examiners
      nullGeorgia Composite Medical Board
      nullFlorida Board of Medicine
      nullArizona Board of Medical Examiners

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2021

      Associate Professor, Baylor College of Medicine, Houston, TX, 2012 - 2018

      Assistant Professor, Nephrology, Baylor College of Medicine, Houston, TX, 2009 - 2012

      Assistant Professor, Internal Medicine, The University of Kansas Medical Center, Witchita, KS, 2006 - 2009

      Administrative Appointments/Responsibilities

      Patient Experience Officer, Mays ACB Clinic, Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present

      Public Safety and Quality Officer, Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present

      Vice Chair, Adult Medicine Faculty Group, Baylor College of Medicine, Houston, TX, 2016 - 2018

      Other Professional Positions

      Member, Baylor College of Medicine,Eisenberg Center for Clinical Decisions & Communication Science,, Houston, TX, 2011 - Present

      Honors & Awards

      2015Rising Star Clinician Award, Baylor College of Medicine 2015
      2014Teacher of the Year, Nephrology
      2002National Champion in Medical Jeopardy, ACP ASIM annual meet: Philadelphia
      2002Pfizer Fellowship in Health Policy and Administration, American College of Preventive Medicine, Washington DC
      1994Honors in Microbiology
      1994Honors in Pharmacology
      1992Gold Medal in Anatomy
      1992Honors in Physiology
      1991Gold Medal in Biochemistry

      Professional Memberships

      Dialysis Steering Committee

      2019 - Present

      Dialysis Quality Committee

      2019 - Present

      Hypertonic Saline Work Group

      2019 - Present

      Patient Safety and Experience Committee

      2019 - Present

      American Medical Association

      2006 - Present

      ACP-ASIM

      2006 - Present

      National Kidney Foundation

      2006 - Present

      Renal Physician Association

      2006 - Present

      American College of Preventive Medicine

      2006 - Present

      American Society of Nephrology

      2006 - Present

      International Society of Nephrology

      2006 - Present

      American Society of Transplantation

      2006 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Pegloticase in Tumor Lysis syndrome: Results of a pilot trial at MD Anderson Cancer Center. Invited. American Society of Nephrology (ASN) 2025. Houston, Texas, US.
      2. 2019. "Chronic kidney disease management". Conference. MD Anderson. Houston, TX, US.
      3. 2018. Renal Grand Rounds: Economics of Health Care. Conference. Houston Methodist Blue Bird Auditorium. Houston, TX, US.
      4. 2017. Renal Grand Rounds: Update on Meso-American Nephropathy. Conference. Houston Methodist Blue Bird Auditorium. Houston, TX, US.

      National Presentations

      1. 2019. Effective of Oral Ferric Citrate on Anemia in ESRD patients with high ferritin. Invited. American Society of Nephrology Annual Meeting, US.
      2. 2018. Disorders of Sodium Balance. Invited. Medical Student Physiology Lectures, US.
      3. 2005. Improvements in Survival of Type 1 Diabetics with End Stage Renal Disease:. Invited. ASN Free Communication Session, US.

      International Presentations

      1. 2025. Effect of Peglocticase in patients with Tumor Lysis Syndrome. Invited. World Congress of Nephrology. Houston, US.
      2. 2018. Lectures on Hyponatremia, Hypernatremia and Respiratory Alkalosis. Invited. CME symposium. Sydney, AU.
      3. 2017. SONG Hemodialysis Outcomes Project: Findings and Future plans Mexican Society of Nephrology. Invited. SONG Hemodialysis Outcomes Project: Findings and Future plans Mexican Society of Nephrology. Chihuahua, MX.
      4. 2017. Progress on Meso-American Nephropathy: Nicaragua Experience: Mexican Society of Nephrology. Invited. Progress on Meso-American Nephropathy: Nicaragua Experience: Mexican Society of Nephrology. Chihuahua, MX.

      Formal Peers

      1. 2019. Post Transplant FSGS. Invited. Cleveland, OH, US.
      2. 2018. Renal Emergencies. Invited, US.
      3. 2018. Disorders of Sodium Balance. Invited, US.
      4. 2018. Introduction to business of Nephrology to Medical Students. Visiting. Houston, TX, US.
      5. 2017. Renal Emergencies. Invited, US.
      6. 2017. Disorders of Sodium Balance. Invited, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2020 - 2021
      Title:Pegloticase for treatment of Tumor Lysis Syndrome: Horizon Biopharmaceuticals
      Funding Source:Horizon Biopharmaceuticals
      Role:PI
      Date: 2020
      Title:Cell free DNA monitoring in Kidney transplant recipients undergoing immunotherapy for cancer
      Funding Source:Care DX
      Role:PI
      Date: 2019 - 2024
      Title:Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients with Selected Unresectable or Metastatic Cancers
      Funding Source:NIH/NCI
      Role:Co-PI
      Date: 2016 - 2019
      Title:Effect of Ferric Citrate on ESRD patients with elevated Ferritin
      Funding Source:Akebia Therapeutics
      Role:Co-PI
      Title:Investigation of Infectious causes of Mes-American Nephropathy
      Funding Source:Center of Global Health - BCM
      Role:Co-I
      Title:Effect of Auryxia on ESA Utilization in ESRD patients with high Ferritin and low Transferrin saturation
      Funding Source:Keryx Biopharmaceuticals
      Role:Co-I
      Title:ESRD Registry
      Funding Source:Institutional Funding
      Role:Co-I
      Title:Epidemiology, Health Services
      Funding Source:Institutional Funding
      Role:Co-I
      Title:Transplant
      Funding Source:Institutional Funding
      Role:Investigator
      Title:Standardized Outcomes In Nephrology
      Funding Source:Song-HD
      Role:Investigator
      Title:Urine microbiome in Stone formers
      Funding Source:NASA/NSBRI
      Role:Co-I
      Title:NIH-STTR Phase I grant
      Funding Source:NIH Funding
      Role:Co-I
      Title:Investigation on Infectious causes of Meso-American Nephropathy
      Funding Source:Philanthropic Funding
      Role:Co-I

      Selected Publications

      Peer-Reviewed Articles

      1. Sajjad, A, Amer, R, Alsayed, M, Butt, MD, Mandayam, S, Sajjad, M, Masood, AR. Case report. BMC nephrology 27(1), 2026. e-Pub 2026. PMID: 41992156.
      2. Cintrón-García, JJ, Patel, M, Andersen, C, Page, VD, Workeneh, BT, Mandayam, S, Al-Dallal, R, Abudayyeh, A, Mamlouk, O. Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes Mellitus. Kidney International Reports 11(6), 2026. e-Pub 2026. PMID: 42179813.
      3. Madan, A, Yalavarthy, R, Kim, DK, Moon, JY, Park, I, Mandayam, S, Cortazar, FB, Kim, SG, Enstrom, A, Thomas, H, Li, J, Peng, SL, Chen, YC, Sanders, JL, Egbuna, O, Tumlin, JA. Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. Kidney International Reports 11(1):106-116, 2026. e-Pub 2026. PMID: 41541780.
      4. Fitz-Patrick D, McVinnie DS, Jackson LA, Crowther G, Geevarughese A, Cannon KD, Garcia LM, Pineiro Puebla Y, Yi Z, Cunliffe L, Maniar A, Zareba AM, Ianos CA, Gomme E, Koury K, Suphaphiphat Allen P, Anderson AS, Gurtman A, Lindert K. Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. N Engl J Med 393(20):2001-2011, 2025. e-Pub 2025. PMID: 41259756.
      5. Huepenbecker, S, Iniesta-Donate, M, Munsell, M, Mandayam, S, Ratanasrimetha, P, Cain, K, Mena, GE, Lasala, J, Ramirez, PT, Meyer, LA. No increase in chronic kidney disease after postoperative acute kidney injury in gynecologic oncologic ERAS surgery. Gynecologic oncology 198:168-175, 2025. e-Pub 2025. PMID: 40505183.
      6. Wijewickrama, E, Behera, S, Garcia, P, Avila-Casado, C, Caplin, B, Paolo, VS, Courville, KJ, Friedman, D, Madero, M, Jha, V, Kambham, N, Levin, A, Anand, S, Bavanandan, S, Bajpai, D, Brown, JM, Daniel, C, de Broe, M, Enghard, P, Fuentes, AF, Fire, AZ, Fischer, RS, González-Quiroz, M, Herath, C, Honsova, E, Johnson, RJ, Kanjanabuch, T, Bandi, VK, Mandayam, S, Mikhailov, A, Nanayakkara, N, Nishanthi, N, Nlandu, YM, Pippias, M, Prasad, NM, Alam, MR, Polo, VS, Seshan, SV, Sheikh-Hamad, D, Singh, G, Strasma, A, Tzanno-Martins, C, Ulasi, I, Vervaet, BA, Waikar, SS, Wijkström, J, Yang, CW. Kidney biopsies among persons living in hotspots of CKDu. Kidney International 105(3):464-469, 2024. e-Pub 2024. PMID: 38160755.
      7. Stern, L, Johnson, RJ, Shakouri, P, Athavale, A, Padnick-Silver, L, LaMoreaux, B, Marder, BA, Mandayam, S. Prevalence and Influence of Gout in Patients with Advanced Chronic Kidney Disease. Gout, Urate, and Crystal Deposition Disease 2(1):77-85, 2024. e-Pub 2024.
      8. Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. N Engl J Med 390(1):20-31, 2024. e-Pub 2024. PMID: 37916620.
      9. Iorgulescu JB, Shaw LK, Rashid A, Rao P, Mandayam S, Patel KP, Schmeler KM, Yang RK, Msaouel P. Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing. Curr Oncol 30(10):9019-9027, 2023. e-Pub 2023. PMID: 37887551.
      10. Spitz EC, Dittmar HB, Lee VL, Bearden DL, Kalentar-Zadeh K, Moore LW, Mandayam S. Nutritional Management of Patients With Both Chronic Kidney Disease and Cancer. J Ren Nutr 33(5):615-617, 2023. e-Pub 2023. PMID: 37553059.
      11. Yi, TW, Smyth, B, Di Tanna, GL, Arnott, C, Cardoza, K, Kang, A, Pollock, CA, Agarwal, R, Bakris, GL, Charytan, D, De Zeeuw, D, Heerspink, HJ, Neal, B, Wheeler, DC, Cannon, CP, Zhang, H, Zinman, B, Perkovic, V, Levin, A, Mahaffey, KW, Jardine, MJ, Brenner, B, Greene, TH, Meininger, G, Li, N, Kolesnyk, I, Aizenberg, D, Pecoits-Filho, R, Cherney, D, Obrador, G, Chertow, G, Chang, TI, Hawley, C, Ji, L, Wada, T, Jha, V, Lim, SK, Lim-Abrahan, MA, Santos, F, Chae, DW, Hwang, SJ, Vazelov, E, Rychlík, I, Hadjadj, S, Krane, V, Rosivall, L, De Nicola, L, Dreval, A, Nowicki, M, Mandayam, S. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex. American Journal of Kidney Diseases 82(1):84-96.e1, 2023. e-Pub 2023. PMID: 36889425.
      12. Heerspink, HJ, Radhakrishnan, J, Alpers, C, Barratt, J, Bieler, S, Diva, U, Inrig, J, Komers, R, Mercer, A, Noronha, IL, Rheault, MN, Rote, W, Rovin, B, Trachtman, H, Trimarchi, H, Wong, MG, Perkovic, V, Alarmartine, E, Chae, DW, Del Vecchio, L, Floege, J, Hwang, SJ, Jelakovic, B, Maes, B, Malecki, R, Miglinas, M, Nolasco, FB, Praga, M, Rabindranath, K, Rosenberg, M, Tang, SC, Tesar, V, Bose, B, Gangadharan, M, McDonald, SP, Peh, C, Jahan, S, Yeap, C, Clayton, P, Irish, G, Thyagarajan, N, Hollett, P, Krishnasamy, R, Carroll, R, Jesudason, S, Crail, S, Coates, T, Waugh, J, Mandayam, S, Workeneh, BT. Sparsentan in patients with IgA nephropathy. The Lancet 401(10388):1584-1594, 2023. e-Pub 2023. PMID: 37015244.
      13. Carstens MH, García N, Mandayam S, Workeneh B, Pastora I, Calderón C, Bertram KA, Correa D. Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy). Stem Cells Transl Med 12(1):7-16, 2023. e-Pub 2023. PMID: 36545894.
      14. Holliday MW, Li Q, Bustamante EG, Niu J, Huang L, Espina IM, Dominguez JR, Truong L, Murray KO, Fan L, Anumudu SJ, Shah M, Fischer RSB, Vangala C, Mandayam S, Perez J, Pan JS, Ali S, Awan AA, Sheikh-Hamad D. Potential Mechanisms Involved in Chronic Kidney Disease of Unclear Etiology. Clin J Am Soc Nephrol. e-Pub 2022. PMID: 35944911.
      15. Strasma AK, Worrall H, Vangala C, Silva Cabrera RM, Mandayam SA, Murray KO, Fischer RSB. Urinary Findings Among Adults and Children in a Region of Nicaragua Endemic for Mesoamerican Nephropathy. Kidney Int Rep 7(2):327-329, 2022. e-Pub 2022. PMID: 35155872.
      16. Mamlouk O, Nair R, Iyer SP, Edwards A, Neelapu SS, Steiner RE, Adkins SA, Hawkins M, Saini N, Devashish K, Strati P, Mandayam S, Ahmed S. Safety of CAR T-cell therapy in kidney transplant recipients. Blood 137(18):2558-2562, 2021. e-Pub 2021. PMID: 33512386.
      17. Strasma A, Coke H, Mamlouk O, Tchakarov A, Mandayam S. Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor. Kidney Med 3(2):294-298, 2021. e-Pub 2021. PMID: 33851126.
      18. Workeneh BT, Mandayam S. Promoting Peritoneal Dialysis Retention in Underserved Communities. Am J Med Sci 361(1):1-2, 2021. e-Pub 2021. PMID: 33422190.
      19. Abudayyeh A, Song J, Abdelrahim M, Dahbour I, Page VD, Zhou S, Shen C, Zhao B, Pai RN, Amaram-Davila J, Manzano JG, George MC, Yennu S, Mandayam SA, Nates JL, Moss AH. Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival. Am J Hosp Palliat Care:1049909120902115. e-Pub 2020. PMID: 31986903.
      20. Fischer RSB, Unrine JM, Vangala C, Sanderson WT, Mandayam S, Murray KO. Evidence of nickel and other trace elements and their relationship to clinical findings in acute Mesoamerican Nephropathy: A case-control analysis. PLoS One 15(11):e0240988, 2020. e-Pub 2020. PMID: 33170853.
      21. Zhang HH, Cortés-Penfield NW, Mandayam S, Niu J, Atmar RL, Wu E, Chen D, Zamani R, Shah MK. Dialysis Catheter-Related Bloodstream Infections in Patients Receiving Hemodialysis on an Emergency-Only Basis: A Retrospective Cohort Analysis. Clin Infect Dis 68(6):1011-1016, 2019. e-Pub 2019. PMID: 29986016.
      22. Adrogué HJ, Mandayam S, Tighiouart H, Madias NE. Osmotic and Nonosmotic Sodium Storage during Acute Hypertonic Sodium Loading. Am J Nephrol 50(1):1-8, 2019. e-Pub 2019. PMID: 31216539.
      23. Fischer RSB, Vangala C, Mandayam S, Chavarria D, García-Trabanino R, Garcia F, Garcia LL, Murray KO. Clinical markers to predict progression from acute to chronic kidney disease in Mesoamerican nephropathy. Kidney Int 94(6):1205-1216, 2018. e-Pub 2018. PMID: 30466566.
      24. Fischer RSB, Vangala C, Truong L, Mandayam S, Chavarria D, Granera Llanes OM, Fonseca Laguna MU, Guerra Baez A, Garcia F, García-Trabanino R, Murray KO. Early detection of acute tubulointerstitial nephritis in the genesis of Mesoamerican nephropathy. Kidney Int 93(3):681-690, 2018. e-Pub 2018. PMID: 29162294.
      25. Navaneethan SD, Mandayam S. Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease. Kidney Int Rep 3(2):244-246, 2018. e-Pub 2018. PMID: 29725628.
      26. Shah MK, Mandayam S, Adrogué HJ. Osmotic Demyelination Unrelated to Hyponatremia. Am J Kidney Dis 71(3):436-440, 2018. e-Pub 2018. PMID: 29277507.
      27. Venkatasubba Rao CP, Bershad EM, Calvillo E, Maldonado N, Damani R, Mandayam S, Suarez JI. Real-time Noninvasive Monitoring of Intracranial Fluid Shifts During Dialysis Using Volumetric Integral Phase-Shift Spectroscopy (VIPS): A Proof-of-Concept Study. Neurocrit Care 28(1):117-126, 2018. e-Pub 2018. PMID: 28547320.
      28. Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, Navaneethan SD, Ramanathan V. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol 48(6):472-481, 2018. e-Pub 2018. PMID: 30472701.
      29. Murray KO, Kolodziej S, Ronca SE, Gorchakov R, Navarro P, Nolan MS, Podoll A, Finkel K, Mandayam S. Visualization of West Nile Virus in Urine Sediment using Electron Microscopy and Immunogold up to Nine Years Postinfection. Am J Trop Med Hyg 97(6):1913-1919, 2017. e-Pub 2017. PMID: 29141749.
      30. Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Sautenet B, O'Donoghue D, Tam-Tham H, Youssouf S, Mandayam S, Ju A, Hawley C, Pollock C, Harris DC, Johnson DW, Rifkin DE, Tentori F, Agar J, Polkinghorne KR, Gallagher M, Kerr PG, McDonald SP, Howard K, Howell M, Craig JC, Nephrology–Hemodialysis Initiative SOI. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis 70(4):464-475, 2017. e-Pub 2017. PMID: 28238554.
      31. Fischer RSB, Mandayam S, Chavarria D, Vangala C, Nolan MS, Garcia LL, Palma L, Garcia F, García-Trabanino R, Murray KO. Clinical Evidence of Acute Mesoamerican Nephropathy. Am J Trop Med Hyg 97(4):1247-1256, 2017. e-Pub 2017. PMID: 28722618.
      32. Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O'Donoghue D, Tam-Tham H, Halimi JM, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T, Craig JC. Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. Transplantation 101(8):1875-1886, 2017. e-Pub 2017. PMID: 28738403.
      33. Winkelmayer WC, Goldstein BA, Mitani AA, Ding VY, Airy M, Mandayam S, Chang TI, Brookhart MA, Fishbane S. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. Am J Kidney Dis 69(6):771-779, 2017. e-Pub 2017. PMID: 28063734.
      34. Vasudevan DA, Northrup TF, Mandayam S, Bamidele OO, Stotts AL. Impact of Physician Training on Diagnosis and Counseling of Overweight and Obese Asian Patients. J Racial Ethn Health Disparities 4(3):322-328, 2017. e-Pub 2017. PMID: 27129859.
      35. Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, Crowe S, Van Biesen W, Winkelmayer WC, O'Donoghue D, Tam-Tham H, Shen JI, Pinter J, Larkins N, Youssouf S, Mandayam S, Ju A, Craig JC, Investigators S. Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. Am J Kidney Dis 69(1):97-107, 2017. e-Pub 2017. PMID: 27497527.
      36. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis 68(3):414-21, 2016. e-Pub 2016. PMID: 27130720.
      37. Airy M, Mandayam S, Mitani AA, Chang TI, Ding VY, Brookhart MA, Goldstein BA, Winkelmayer WC. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. Nephrol Dial Transplant 30(12):2068-75, 2015. e-Pub 2015. PMID: 26311216.
      38. Murray KO, Fischer RS, Chavarria D, Duttmann C, Garcia MN, Gorchakov R, Hotez PJ, Jiron W, Leibler JH, Lopez JE, Mandayam S, Marin A, Sheleby J. Mesoamerican nephropathy: a neglected tropical disease with an infectious etiology?. Microbes Infect 17(10):671-5, 2015. e-Pub 2015. PMID: 26320026.
      39. Sangsiraprapha W, Truong L, Mandayam S. ANCA-mediated crescentic glomerulonephritis with linear deposition of IgG along the glomerular basement membrane. Saudi J Kidney Dis Transpl 25(3):634-7, 2014. e-Pub 2014. PMID: 24821165.

      Review Articles

      1. Alkhulaifawi, M, Mandayam, S, Mousa, A, Bugazia, D, Al Najjar, E, Khasawneh, B, Ali, S, Esmail, A. Membranous-like glomerulopathy with monoclonal immunoglobulin deposits in a patient with class V lupus nephritis. Exploration of Medicine 6, 2025. e-Pub 2025.
      2. Perissinotti AJ, Bishop MR, Bubalo J, Geyer MB, Goodrich A, Howard SC, Kula J, Mandayam S, Cairo MS, Pui CH. Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel. Cancer Treat Rev 120:102603, 2023. e-Pub 2023. PMID: 37579533.
      3. Turcotte A, Achi S, Mamlouk O, Mandayam S. Electrolytes disturbances in cancer patients. Curr Opin Nephrol Hypertens 31(5):425-434, 2022. e-Pub 2022. PMID: 35894276.

      Editorials

      1. Mandayam S, Winkelmayer WC. Barriers to home dialysis initiation. The precious first few weeks. American Journal of Medicine, 2020.
      2. Mandayam S, Winkelmayer WC. Worldwide Preparedness for Kidney Health Care. JAMA 317(18):1838-1839, 2017. PMID: 28430831.

      Abstracts

      1. Perissinotti AJ, Bishop MR, Bubalo J, Geyer MB, Goodrich A, Howard SC, Kula J, Mandayam S, Cairo MS, Pui CH. Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel. Cancer Treat Rev 120:102603, 2023. e-Pub 2023. PMID: 37579533.
      2. Iorgulescu JB, Shaw LK, Rashid A, Rao P, Mandayam S, Patel KP, Schmeler KM, Yang RK, Msaouel P. Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing. Curr Oncol 30(10):9019-9027, 2023. e-Pub 2023. PMID: 37887551.
      3. Spitz EC, Dittmar HB, Lee VL, Bearden DL, Kalentar-Zadeh K, Moore LW, Mandayam S. Nutritional Management of Patients With Both Chronic Kidney Disease and Cancer. J Ren Nutr 33(5):615-617, 2023. e-Pub 2023. PMID: 37553059.

      Book Chapters

      1. Mandayam S, Imran NB, Mitch WE. Nutrition in patients with Chronic Kidney Disease. In: Text Book of Kidney Disease. 1st, 2014.
      2. Mandayam S, Mitch WE, Kopple J. Dietary factors influencing the course of chronic kidney disease. In: Diseases of the Kidney & Urinary Tract. 9th, 2012.
      3. Mandayam S, Mitch WE. Protein Intake & Prevention of chronic renal disease. In: Diseases of the Kidney. 8th, 2627-2696, 2007.
      4. Mandayam S, Mitch WE. Dietary requirements for protein & calories in the pre-dialysis patient. In: Handbook of Nutrition and the Kidney. 5th, 115-137, 2005.

      Letters to the Editor

      1. Mamlouk O, Strati P, Feng L, Sun R, Ayers A, Steiner RE, Nair R, Flowers C, Ramdial JL, Saini N, Srour SA, Champlin RE, Kebriaei P, Nastoupil LJ, Rodriguez MA, Shpall EJ, Nieto Y, Westin J, Neelapu SS, Mandayam S, Ahmed S. Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function. Br J Haematol.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 15, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top